Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-15

FDA Approved: DECITABINE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s generic decitabine via an Original Application, enabling the same indications as the brand product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Decitabine (Decitabine)

Snippet

ORIG AP for DECITABINE (DECITABINE)